| Carr, Brian I; Akkiz, Hikmet; Üsküdar, Oguz et al. (2018) HCC with low- and normal-serum alpha-fetoprotein levels. Clin Pract (Lond) 15:453-464 |
| Carr, Brian I; Akkiz, Hikmet; Guerra, Vito et al. (2018) C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors. Clin Pract (Lond) 15:625-634 |
| Akkiz, Hikmet; Carr, Brian I; Yalç?n K, Kendal et al. (2018) Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients. Oncology 94:116-124 |
| Akkiz, Hikmet; Carr, Brian I; Kuran, Sedef et al. (2018) Macroscopic Portal Vein Thrombosis in HCC Patients. Can J Gastroenterol Hepatol 2018:3120185 |
| Carr, Brian I; Guerra, Vito; Giannini, Edoardo G et al. (2016) A Liver Index and its Relationship to Indices of HCC Aggressiveness. J Integr Oncol 5: |
| Pan?oška, Petr; Skála, Lubomír; Nešet?il, Jaroslav et al. (2015) Evaluation of total hepatocellular cancer lifespan, including both clinically evident and preclinical development, using combined network phenotyping strategy and fisher information analysis. Semin Oncol 42:339-46 |
| D'Alessandro, Rosalba; Refolo, Maria Grazia; Lippolis, Catia et al. (2015) Modulation of Regorafenib effects on HCC cell lines by epidermal growth factor. Cancer Chemother Pharmacol 75:1237-1245 |
| Carr, Brian I; Lin, Chih-Yun; Lu, Sheng-Nan (2014) Platelet-related phenotypic patterns in hepatocellular carcinoma patients. Semin Oncol 41:415-21 |
| Refolo, Maria Grazia; D'Alessandro, Rosalba; Lippolis, Catia et al. (2014) Modulation of Doxorubicin mediated growth inhibition of hepatocellular carcinoma cells by platelet lysates. Anticancer Agents Med Chem 14:1154-60 |
| Pancoska, Petr; Carr, Brian I (2014) Macro- and micro-environmental factors in clinical hepatocellular cancer. Semin Oncol 41:185-94 |
Showing the most recent 10 out of 55 publications
